Xylem (XYL) Tops Q2 EPS by 12c, Misses on Revenue; Offers FY26 Guidance

Xylem (NYSE: XYL) reported Q2 EPS of $1.46, $0.12 better than the analyst estimate of $1.34. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.35 billion.

GUIDANCE:

Xylem sees FY2026 EPS of $5.55-$5.70, versus the consensus of $5.54. Xylem sees FY2026 revenue of $9.2 billion, versus the consensus of $9.25 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Airbnb Inc. (ABNB) PT Raised to $200 at Baird
• Guggenheim Reiterates Buy Rating on Oracle (ORCL)